← SynDRA
STAUROSPORINE AGLYCON
SynDRA canonical compound SYN0000221 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | CCND1 |
|---|
| Mechanism of action | CDK inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- cyclin-dependent kinase inhibitor
Cross-references
Synonyms
- arcyriaflavin-a
- Arcyriaflavin A
- RefChem:916127
- DTXCID50366981
- MFCD03452662
- A7F
- BDBM2672
- orb1704942
- SCHEMBL6598816
- SCHEMBL8124103
- SCHEMBL29406635
- SCHEMBL29612333
- SCHEMBL30530825
- CHEBI:93276
- C20H11N3O2
- GLXC-04853
- HMS3229B05
- HMS3269E19
- HMS3413O10
- HMS3677O10
- EX-A9361
- LSM-3627
- TEA45854
- AKOS024457112
- EBC-473041
- NCGC00159573-01
- NCGC00159573-02
- DB-081253
- HY-103382
- CS-0027783
- G13211
- T21858
- BRD-K72726508-001-01-3
- BRD-K72726508-001-02-1
- BRD-K72726508-001-03-9
- maleimide indolocarbazole
- arcyriaflavin A
Look up STAUROSPORINE AGLYCON in the interactive SynDRA portal →